Certified by Founder Lodge
Diagonal Therapeutics
United States - Watertown, Massachusetts
START UP
1 Disclosed Funding Rounds $125,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases. Using our DIAGONAL platform, we engineer clust
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 13 ,2026 | Series B | $125,000,000 |
Sanofi
Viking Global Investors
Atlas Ventures
Janus Henderson Investors
Balyasny Asset Management L.P.
Logos Capital
EcoR1 Capital, LLC
Frazier Life Sciences
Biovision Ventures
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
